Pharmacologic Class Information
|Pharmacologic Name||Glycoprotein 100 Peptide-Human Leukocyte Antigen-directed Antibody Interactions|
|Pharmacologic Concept||Mechanisms of Action - [MoA]|
|Pharmacologic Concept Description||This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.|
NDC Products with Glycoprotein 100 Peptide-Human Leukocyte Antigen-directed Antibody Interactions
The following table contains 1 products whose active ingredient are classified under the same pharmacologic class Glycoprotein 100 Peptide-Human Leukocyte Antigen-directed Antibody Interactions [MoA].
|NDC||Proprietary Name||Non-Proprietary Name||Dosage Form||Route Name||Company Name||Status|
|80446-401||Kimmtrak||Non-Proprietary Name: Tebentafusp||Injection, Solution, Concentrate||Intravenous||Immunocore Commercial Llc||ACTIVE|